BRIDGEBIO PHARMA INC (BBIO)
8 tracked managers currently hold BBIO on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | Q3 2026 | TRIM | $644.3M | 2.0 % | 2.1 % | 9,792,219 | -157,000 |
| TWO SIGMA INVESTMENTS, LP | Q3 2026 | TRIM | $240.8M | 0.2 % | 0.3 % | 3,660,083 | -1,062,102 |
| D. E. Shaw & Co., Inc. | Q3 2026 | TRIM | $146.3M | 0.1 % | 0.2 % | 2,223,190 | -1,409,817 |
| CITADEL ADVISORS LLC | Q3 2026 | TRIM | $113.5M | 0.1 % | 0.2 % | 1,725,205 | -2,034,823 |
| RENAISSANCE TECHNOLOGIES LLC | Q3 2026 | TRIM | $56.4M | 0.1 % | 0.1 % | 856,546 | -300 |
| Bridgewater Associates, LP | Q3 2026 | ADD | $45.8M | 0.2 % | 0.1 % | 695,638 | +247,495 |
| MILLENNIUM MANAGEMENT LLC | Q3 2026 | ADD | $40.9M | 0.0 % | 0.0 % | 622,296 | +134,702 |
| Point72 Asset Management, L.P. | Q3 2026 | TRIM | $39.6M | 0.1 % | 0.2 % | 602,374 | -923,408 |